Sarthak Metals Q3 FY26 Earnings Analysis

Published 8 Aug 2026 | Industrial Products | Market Cap: ₹95 Cr

Price

69.4

Market Cap

₹95 Cr

P/E Ratio

20.6

Revenue Rank

Rank 3

Margin Rank

Rank 3

Earnings Summary

- Welding division targets ₹25 crore sales revenue in the next 2 years, with current growth trajectory supporting this confidence (Page 12, 14). - Biotech revenue expected to start soon with healthy double-digit margins (Page 16).

📊 Revenue & Sales Performance

Rank 3

- Welding division targets ₹25 crore sales revenue in the next 2 years, with current growth trajectory supporting this confidence (Page 12, 14). - Plans to expand welding SKUs from 5 to 10 within 12-24 months (Page 13). - Biotech revenue expected to start very soon, with positive industry discussions underway (Page 13, 16). - Core business volumes declined 14% YoY in Q2 FY26 due to monsoon and competition but viewed as temporary setback; focus on regaining market share through service quality (Page 14). - Company aims for diversified growth with three pillars: core cored wire and aluminum wires, welding consumables, and biotechnology (Page 7, 8). - Biotech market size estimated over ₹1,000 crore with huge opportunity due to government biofuel policies (Page 7). - Strong optimism on infrastructure-driven steel demand long-term despite short-term challenges (Page 5). - Expectation of improved EBITDA margins once sales targets and brand establishment are achieved (Page 14, 16).

📈 Profitability & Margins

Rank 3

- Biotech revenue expected to start soon with healthy double-digit margins (Page 16). - Welding division targeting ₹25 crore sales in next 2 years with EBITDA margins improving to 9-10% once brand is established (Pages 12-15). - By FY28, biotech and welding divisions aiming comfortable double-digit margins; core businesses may contribute 10-15% EBITDA, but 25% per business is unlikely (Page 16). - Focus on establishing strong brand in welding to achieve sustainable margin growth (Pages 14-15). - Company expects growth driven by diversification into biotech and welding alongside core cored wire business, which faces short-term cyclicity but has strong long-term potential (Pages 7-9). - Committed to improving profitability while maintaining financial discipline and no significant reliance on government incentives (Pages 8, 16). - Management optimistic about long-term value creation despite short-term steel sector challenges (Page 9).

🏗️ Capital Expenditure Plans

Yes

- The steel sector is undergoing CapEx cycles with major steel plants like JSPL and JSW continuing their investments, though the urgency to complete these projects quickly has decreased (Page 11, 12:34-12:57). - Sarthak Metals is not currently focusing on government grants or incentives for its biotech division but is actively seeking external partnerships with established players to share technology (Page 16, 20:44-21:25). - The company made a strategic decision to temporarily step back from the aluminium flipping coil segment to protect profitability amid unethical competition, with plans to resume full capacity when market conditions stabilize (Page 6, 5:23-5:58). - The biotechnology division represents a future growth engine with ongoing advanced discussions and a significant market opportunity driven by the government’s biofuel mission (Page 7, 7:11-8:23). - Overall, the company remains financially strong and virtually debt free, enabling investment flexibility in new growth areas without strain (Page 8, 9:18-9:40).

💰 Fundraising & Capital Structure

No information

- There is no mention of any current or planned new fundraising through debt or equity in the transcript. - The company emphasizes a strong, virtually debt-free balance sheet providing financial firepower and flexibility to invest in new growth areas without straining resources (Page 8, 9:18-9:44). - The focus is on funding future growth internally from a position of strength rather than relying on external capital raising. - The management's financial strategy is disciplined prudence, without references to upcoming capital raising (Page 8). - No questions were raised or answered regarding new fundraising during the Q&A session.

📋 Order Book & Pipeline

No

- The demand for steel and related products remains robust with order books at fabrication and construction houses filled. (Page 12, 14:03) - Despite a 14% YoY decline in Q2 volumes in the cored wire segment due to monsoon and intensified competition, the company retains existing orders and focuses on ethical execution to regain market trust. (Page 14, 16:35; Page 14, 17:30) - No explicit numerical value for current order book was disclosed, but the management remains optimistic due to robust demand and filled order books in fabrication/construction sectors. (Page 12, 14:03) - The company is closely watching market conditions, prepared to scale production when feasible, especially in the aluminium flipping coil segment. (Page 6, 5:47) - Overall, the company is confident of growth and anticipates continued order inflows driven by infrastructure projects and government initiatives. (Page 5, 3:22)

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No

Frequently Asked Questions

What were Sarthak Metals Q3 FY26 results?

- Welding division targets ₹25 crore sales revenue in the next 2 years, with current growth trajectory supporting this confidence (Page 12, 14). - Biotech revenue expected to start soon with healthy double-digit margins (Page 16).

What is Sarthak Metals share price analysis?

Sarthak Metals currently shows a below-average growth signal. The stock trades at a P/E of 20.6 with a market cap of ₹95. Investors should review the full earnings analysis for detailed insights.

Is Sarthak Metals planning capital expenditure?

- The steel sector is undergoing CapEx cycles with major steel plants like JSPL and JSW continuing their investments, though the urgency to complete these projects quickly has decreased (Page 11, 12:34-12:57).

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Sarthak Metals's management said in earlier quarters

Others in Industrial Products this season

  • Prince Pipes & Fittings Ltd (Q3 FY26)

    Prince Pipes & Fittings Ltd Q3 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹3,037,

  • Rajshree Polypac (Q3 FY26)

    Rajshree Polypac Q3 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹175, P/E 8.6. AI-p

  • Welspun Corp Ltd (Q3 FY26)

    Welspun Corp Ltd Q3 FY26 quarterly results analysis. - Welspun aims to maintain ROCE above 23-24%, indicating focus on profitability and efficient capital use (

  • HEG Ltd (Q3 FY26)

    HEG Ltd Q3 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹13,242, P/E 37.4. AI-powere